S. Doshi
Journal of the American College of Cardiology · 2009–2017
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom S. Doshi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Doshi overall
Papers from S. Doshi's perspective
Ordered by how strongly the researchers S. Doshi trusts endorse each paper. Same corpus, a different order for every researcher.
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
- Apixaban in patients with atrial fibrillation. (New England Journal of Medicine)
- Bayesian data analysis.
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
- Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
- Bayesian clinical trials
- Bayesian estimation supersedes the t test. (Journal of experimental psychology. General)
- Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based… (Circulation)
Their papers
- 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017) — 947 citations
- Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. (2014) — 1,676 citations
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial (2013) — 625 citations
- Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry (2011) — 889 citations
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. (2009) — 2,045 citations